The National Institute of Allergy and Infectious Diseases (NIAID) Centers of Excellence for Influenza Research and Surveillance (CEIRS) program is an integrated network of centers designed to bring together multidisciplinary teams of researchers that perform surveillance related research integrated with research on host immune response, viral pathogenesis, and the factors that control the emergence and transmission of influenza viruses. The overall goal of the CEIRS network is to provide the information and public health tools needed to control the impact of epidemic influenza and the threat of pandemic influenza.
The CEIRS Network
A Program of the National Institute of Allergy and Infectious Diseases
Due to the ever present threat of an influenza pandemic, the NIAID Centers of Excellence for Influenza Research and Surveillance (CEIRS) program was established to support the research agenda of the HHS Pandemic Influenza Plan.
Capturing the Flu in Colombia with Dr. Dib
Juan C. Dib, MD, MPH/TM, PhD, discusses his career as a multidisciplinary scientist and physician working with indigenous peoples to study influenza and other tropical infectious diseases.
Highlights from the 2016 CEIRS Surveillance Meeting
Hosted by SJCEIRS in Columbus, Ohio, the 2016 meeting attracted 65 researchers to discuss influenza surveillance, pandemic preparedness, and response efforts by the Network.
Improving Influenza Vaccines
CEIRS Trainee Spotlight featuring Teddy John Wohlbold
Mr. Teddy John Wohlbold shares his experience with the CEIRS Training Program and his work on refining antibody responses to the flu.
B-cells, Boosters, and Precision Vaccines
David Topham, PhD, co-Principal Investigator of the New York Influenza Center of Excellence (NYICE), discusses the relationship between an individual’s immune response and seasonal flu viruses and a translational approach to influenza research.
Connecting CEIRS Science to the Public
The CEIRS Reagent Repository page allows influenza researchers to request reagents from CEIRS investigators. Over 4,000 CEIRS-generated plasmids, proteins, antibodies, virus isolates, and reverse genetic viruses are available through the searchable and filterable Reagent Repository.